News
In a landmark shift for consumer genomics, Anne Wojcicki, the co-founder and former CEO of 23andMe, has announced the ...
After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.
Anne Wojcicki lands 23andMe again. What $305 million deal means for company, customers, shareholders
Anne Wojcicki will soon be running 23andMe again. Here's what that means.
DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.
A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...
9d
Stocktwits on MSN23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA PrivacyA U.S. bankruptcy judge has cleared 23andMe’s $305 million sale to TTAM Research, a nonprofit led by co-founder Anne Wojcicki ...
15d
Stocktwits on MSN23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s BidMe Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research Institute, a California-based nonprofit led by company co-founder and ...
NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe ... s signature “Personal Genome Service” provided through the company’s ...
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction.
23andMe CEO Anne Wojcicki has been trying to take the DNA testing company private this past year, making clear along the way that she would oppose any deal to sell the business to someone else.
23andMe Holding Co. Chief Executive Officer Anne Wojcicki has offered to take the struggling DNA-testing company private. Wojcicki on July 29 proposed buying the outstanding shares of 23andMe for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results